Abstract
This study was carried out to investigate the activation status of unfolded protein response (UPR) in colorectal cancer (CRC) and its contribution to CRC resistance to chemotherapy-induced apoptosis. Chemotherapy-induced apoptosis was assessed by the propidium iodide method. Activation of UPR was evaluated in CRC cell lines using immunoblotting technique and in CRC tissues using immunohistochemistry. Findings of the present study revealed that the UPR is constitutively activated in CRC cell lines and CRC tissues isolated from patients, as evidenced by relatively high levels of the 78-kDa glucose-regulated protein (GRP78) and spliced X-box-binding protein 1 mRNA in tissue samples. In addition, CRC cell lines differentially responded to clinically relevant DNA-targeting agents including cisplatin, and 5-flourouracil. Moreover, the levels of GRP78 were inversely associated with sensitivity of CRC cells to chemotherapy-induced apoptosis. Inhibition of GRP78 by siRNA resulted in increased sensitivity of CRC cells to chemotherapeutic agents. Collectively, current results appear to provide novel insights into the role of UPR in determining sensitivity of CRC cells to chemotherapeutic agents and might have important implications for personalized CRC treatment.
Similar content being viewed by others
References
Adeyinka A, Nui Y, Cherlet T, Snell L, Watson PH, Murphy LC (2002) Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression. Clin Cancer Res 8:1747–1753
Booth L, Cazanave SC, Hamed HA, Yacoub A, Ogretmen B, Chen CS, Grant S, Dent P (2012) OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killing. Cancer Biol Ther 13:224–236. doi:10.4161/cbt.13.4.18877
Chang YJ, Huang YP, Li ZL, Chen CH (2012) GRP78 knockdown enhances apoptosis via the down-regulation of oxidative stress and Akt pathway after epirubicin treatment in colon cancer DLD-1 cells. PLoS One 7:e35123. doi:10.1371/journal.pone.0035123
Dong D, Ni M, Li J, Xiong S, Ye W, Virrey JJ, Mao C, Ye R, Wang M, Pen L, Dubeau L, Groshen S, Hofman FM, Lee AS (2008) Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res 68:498–505. doi:10.1158/0008-5472.CAN-07-2950
Erhardt P, Schremser EJ, Cooper GM (1999) B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol Cell Biol 19:5308–5315
Fan LM, Su J, Dong H, Wei M, Cui MH (2013) Inhibition of GRP78 expression reverses cisplatin resistance in human ovarian cancer. Zhonghua Yi Xue Za Zhi 93:1341–1344
Fang JY (2009) Chemoprophylaxis for colorectal cancer: opportunities and challenges. Zhonghua Nei Ke Za Zhi 48:93–94
Firczuk M, Gabrysiak M, Barankiewicz J, Domagala A, Nowis D, Kujawa M, Jankowska-Steifer E, Wachowska M, Glodkowska-Mrowka E, Korsak B, Winiarska M, Golab J (2013) GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy. Cell Death Dis 4:e741. doi:10.1038/cddis.2013.265
Fu Y, Wey S, Wang M, Ye R, Liao CP, Roy-Burman P, Lee AS (2008) Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium. Proc Natl Acad Sci USA 105:19444–19449. doi:10.1073/pnas.0807691105
Galvao J, Davis B, Tilley M, Normando E, Duchen MR, Cordeiro MF (2014) Unexpected low-dose toxicity of the universal solvent DMSO. FASEB J 28:1317–1330. doi:10.1096/fj.13-235440
Gottschalk A, Ford JG, Regelin CC, You J, Mascha EJ, Sessler DI, Durieux ME, Nemergut EC (2010) Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology 113:27–34. doi:10.1097/ALN.0b013e3181de6d0d
Harding HP, Calfon M, Urano F, Novoa I, Ron D (2002) Transcriptional and translational control in the mammalian unfolded protein response. Annu Rev Cell Dev Biol 18:575–599. doi:10.1146/annurev.cellbio.18.011402.160624
Hardy B, Raiter A, Yakimov M, Vilkin A, Niv Y (2012) Colon cancer cells expressing cell surface GRP78 as a marker for reduced tumorigenicity. Cell Oncol (Dordr) 35:345–354. doi:10.1007/s13402-012-0094-4
Jiang CC, Chen LH, Gillespie S, Wang YF, Kiejda KA, Zhang XD, Hersey P (2007) Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis. Cancer Res 67:9750–9761. doi:10.1158/0008-5472.CAN-07-2047
Jin HR, Zhao J, Zhang Z, Liao Y, Wang CZ, Huang WH, Li SP, He TC, Yuan CS, Du W (2012) The antitumor natural compound falcarindiol promotes cancer cell death by inducing endoplasmic reticulum stress. Cell Death Dis 3:e376. doi:10.1038/cddis.2012.122
Lee AS (2007) GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 67:3496–3499. doi:10.1158/0008-5472.CAN-07-0325
Li B, Cheng XL, Yang YP, Li ZQ (2013) GRP78 mediates radiation resistance of a stem cell-like subpopulation within the MCF-7 breast cancer cell line. Oncol Rep 30:2119–2126. doi:10.3892/or.2013.2710
Maurel J, Nadal C, Garcia-Albeniz X, Gallego R, Carcereny E, Almendro V, Mármol M, Gallardo E, Maria Augé J, Longarón R, Martínez-Fernandez A, Molina R, Castells A, Gascón P (2007) Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. Int J Cancer 121:1066–1071. doi:10.1002/ijc.22799
Mhaidat NM, Zhang XD, Jiang CC, Hersey P (2007) Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway. Clin Cancer Res 13:1308–1314. doi:10.1158/1078-0432.CCR-06-2216
Mhaidat NM, Thorne RF, de Bock CE, Zhang XD, Hersey P (2008) Melanoma cell sensitivity to Docetaxel-induced apoptosis is determined by class III beta-tubulin levels. FEBS Lett 582:267–272. doi:10.1016/j.febslet.2007.12.014
Mhaidat NM, Abdul-Razzak KK, Alkofahi AS, Alsarhan AM, Aldaher AN, Thorne RF (2012) Altholactone induces apoptotic cell death in human colorectal cancer cells. Phytother Res 26:926–931. doi:10.1002/ptr.3666
Pi L, Li X, Song Q, Shen Y, Lu X, Di B (2014) Knockdown of glucose-regulated protein 78 abrogates chemoresistance of hypopharyngeal carcinoma cells to cisplatin induced by unfolded protein in response to severe hypoxia. Oncol Lett 7:685–692. doi:10.3892/ol.2013.1753
Pyrko P, Schonthal AH, Hofman FM, Chen TC, Lee AS (2007) The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res 67:9809–9816. doi:10.1158/0008-5472.CAN-07-0625
Reddy RK, Mao C, Baumeister P, Austin RC, Kaufman RJ, Lee AS (2003) Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem 278:20915–20924. doi:10.1074/jbc.M212328200
Rutkowski DT, Kaufman RJ (2007) That which does not kill me makes me stronger: adapting to chronic ER stress. Trends Biochem Sci 32:469–476. doi:10.1016/j.tibs.2007.09.003
Rutkowski DT, Arnold SM, Miller CN, Wu J, Li J, Gunnison KM, Mori K, Sadighi Akha AA, Raden D, Kaufman RJ (2006) Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol 4:e374. doi:10.1371/journal.pbio.0040374
Schroder M, Kaufman RJ (2005) The mammalian unfolded protein response. Annu Rev Biochem 74:739–789. doi:10.1146/annurev.biochem.73.011303.074134
Slotta-Huspenina J, Wolff C, Drecoll E, Feith M, Bettstetter M, Malinowsky K, Bauer L, Becker K, Ott K, Höfler H, Becker KF, Langer R (2013) A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas. Br J Cancer 109:370–378. doi:10.1038/bjc.2013.319
Takahashi K, Yamaguchi T, Matsumoto H, Nakano D, Watanabe F (2011) Clinical appearance of liver metastases from colorectal cancer. Nihon Rinsho 69(Suppl 3):162–165
Xing X, Li Y, Liu H, Wang L, Sun L (2011) Glucose regulated protein 78 (GRP78) is overexpressed in colorectal carcinoma and regulates colorectal carcinoma cell growth and apoptosis. Acta Histochem 113:777–782. doi:10.1016/j.acthis.2010.11.006
Yang L, Yang S, Liu J, Wang X, Ji J, Cao Y, Lu K, Wang J, Gao Y (2014) Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer. Exp Mol Pathol 96:235–241. doi:10.1016/j.yexmp.2014.02.011
Zhang K, Kaufman RJ (2004) Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem 279:25935–25938. doi:10.1074/jbc.R400008200
Zhang Y, Tseng CC, Tsai YL, Fu X, Schiff R, Lee AS (2013) Cancer cells resistant to therapy promote cell surface relocalization of GRP78 which complexes with PI3 K and enhances PI(3,4,5)P3 production. PLoS One 8:e80071. doi:10.1371/journal.pone.0080071
Acknowledgments
We would like to acknowledge the Scientific Research Support Fund at Ministry of Higher Education and Scientific Research, Amman, Jordan, for the financial support (Grant number 118-2011).
Conflict of interest
Authors confirm that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mhaidat, N.M., Alzoubi, K.H., Khabour, O.F. et al. GRP78 regulates sensitivity of human colorectal cancer cells to DNA targeting agents. Cytotechnology 68, 459–467 (2016). https://doi.org/10.1007/s10616-014-9799-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-014-9799-8